Resources: Page 475

Shear-wave elastography improves ultrasound diagnosis of breast masses
By Kate Madden Yee
Wednesday, December 1 | 11:25 a.m.-11:35 a.m. | VB41-13 | Arie Crown TheaterWhen used with B-mode ultrasound, shear-wave elastography -- which quantitatively measures soft-tissue stiffness in real-time -- can improve the modality's specificity without compromising its sensitivity, according to researchers from Imperial College London in the U.K.
November 9, 2010
DBT equivalent to FFDM for cancer detection
By Kate Madden Yee
Wednesday, December 1 | 10:25 a.m.-10:35 a.m. | VB41-08 | Arie Crown TheaterDigital breast tomosynthesis (DBT) finds and identifies breast cancers just as well as full-field digital mammography (FFDM), according to a study to be presented on Wednesday by researchers from Albert Einstein Medical Center in Philadelphia.
November 9, 2010
Contrast-enhanced spectral mammography proves useful adjunct
By Kate Madden Yee
Wednesday, December 1 | 8:35 a.m.-8:45 a.m. | VB41-01 | Arie Crown TheaterIn this paper presentation, researchers will discuss study results showing contrast-enhanced spectral mammography's (CESM) potential to increase the performance and sensitivity of standard mammography and breast ultrasound.
November 9, 2010
Targeted 'second-look' ultrasound finds additional, smaller lesions
By Kate Madden Yee
Tuesday, November 30 | 3:40 p.m.-3:50 p.m. | SSJ02-05 | Room E450AUsing ultrasound to take a second look at women with breast cancer who have already undergone mammography and an initial ultrasound can help find additional, smaller malignant lesions, but many of these belong to lower-risk BI-RADS categories, according to researchers from Hospital Universitario 12 de Octubre in Madrid.
November 9, 2010
'Multiple-bilateral' breast mass malignancy rate comparable to similar lesions
By Kate Madden Yee
Tuesday, November 30 | 3:00 p.m.-3:10 p.m. | SSJ02-01 | Room E450AMalignancy rates for multiple-bilateral breast masses detected at whole-breast ultrasound are comparable to rates for masses with similar features but not categorized as multiple-bilateral, according to researchers from Johns Hopkins at Green Spring Station in Lutherville, MD.
November 9, 2010
CAD aids in assessing amorphous breast calcifications
By Erik L. Ridley
Tuesday, November 30 | 11:30 a.m.-11:40 a.m. | SSG01-07 | Room E450AIn this scientific session, researchers from Princess Margaret Hospital in Toronto will present data showing a high sensitivity for computer-aided detection (CAD) in detecting amorphous calcifications on full-field digital mammography (FFDM) studies.
November 9, 2010
Breast MRI shows high negative predictive value in BI-RADS 3 lesions
By Kate Madden Yee
Monday, November 29 | 3:20 p.m.-3:30 p.m. | SSE01-03 | Room E450ABreast MRI exhibits a high negative predictive value in patients with BI-RADS category 3 lesions, according to a study from the Medical University of Graz in Graz, Austria, to be presented on Monday.
November 9, 2010
Targeted breast US identifies cancer BI-RADS 3 lesions found by MRI
By Kate Madden Yee
Monday, November 29 | 3:00 p.m.-3:10 p.m. | SSE01-01 | Room E450AUsing targeted ultrasound on breast lesions identified as BI-RADS category 3 by MRI can help identify malignancies, according to researchers from Brown University in Providence, RI.
November 9, 2010
PEM shows potential for breast cancer surgical planning
By Kate Madden Yee
Monday, November 29 | 11:40 a.m.-11:50 a.m. | VM21-15 | Arie Crown TheaterIn this scientific session, Johns Hopkins researchers will present study results suggesting that positron emission mammography (PEM) is a helpful tool for breast cancer surgical planning in early-stage breast cancer.
November 9, 2010
Positron emission mammography can be more specific than MRI
By Kate Madden Yee
Monday, November 29 | 9:25 a.m.-9:35 a.m. | VM21-06 | Arie Crown TheaterPositron emission mammography (PEM) is more specific than MRI for surgical management in women with ipsilateral breast cancer, according to researchers from Johns Hopkins at Green Spring Station in Lutherville, MD.
November 9, 2010
BSGI improves breast cancer detection -- but biopsies may still be needed
By Kate Madden Yee
Monday, November 29 | 9:05 a.m.-9:15 a.m. | VM21-04 | Arie Crown TheaterBreast-specific gamma imaging (BSGI) improves the detection of breast cancer, but the modality doesn't do away with the need for biopsy when indicated by mammography or ultrasound, according to researchers from Weinstein Imaging Associates in Pittsburgh.
November 9, 2010
MBI increases breast cancer detection in dense tissue
By Kate Madden Yee
Monday, November 29 | 8:55 a.m.-9:05 a.m. | VM21-03 | Arie Crown TheaterIn this paper presentation, researchers from the Mayo Clinic in Rochester, MN, will discuss how adding molecular breast imaging (MBI) to regular screening mammography for women with dense breasts increases cancer detection.
November 9, 2010
Previous Page
Page 475 of 726
Next Page